Normal tension glaucoma is not associated with the interleukin -1α (-889) genetic polymorphism

Journal of Glaucoma

Volumn 16, Issue 2, 2007, Pages 230-233

  Wang, Chun Yuan ^a,c,e   Shen, Ying Cheng ^a,d   Lo, Fai Yun ^b   Su, Chien Hui ^b   Lee, Shi Huang ^a   Tsai, Hin Yeung ^a   Fan, Seng Sheen ^b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TUNGHAI UNIVERSITY   (Taiwan)

^c HUNGKUANG UNIVERSITY   (Taiwan)

^d OVERSEAS CHINESE INSTITUTE OF TECHNOLOGY   (Taiwan)

^e TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Alzheimer disease; Interleukin 1 ( 889) genetic polymorphism; Intraocular pressure (IOP); Normal tension glaucoma (NTG); Optic neuropathy

Indexed keywords

GENOMIC DNA; INTERLEUKIN 1ALPHA;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INTRAOCULAR PRESSURE; LOW TENSION GLAUCOMA; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTERLEUKIN-1ALPHA; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 34247594444     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/IJG.0b013e3180300818     Document Type: Article

References (24)

1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262-267.
2. Kamal D, Hitchings R. Normal tension glaucoma - a practical approach. Br J Ophthalmol. 1998;82:835-840.
3. Vickers JC, Dickson TC, Adlard PA, et al. The cause of neuronal degeneration in Alzheimer's disease. Prog Neurobiol. 2000;60:139-165. Review.
4. McKinnon SJ. Glaucoma: ocular Alzheimer's disease? Front Biosci. 2003;8:S1140-S1156. Review.
5. McKinnon SJ, Lehman DM, Kerrigan-Baumrind LA, et al. Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest Ophthalmol Vis Sci. 2002;43:1077-1087.
6. Wisniewski T, Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett. 1992;135:235-238.
7. Rebeck GW, Reiter JS, Strickland DK, et al. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron. 1993;11:575-580.
8. Schmechel DE, Saunders AM, Strittmatter WJ, et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Proc Natl Acad Sci U S A. 1993;90:9649-9653.
9. Ma J, Yee A, Brewer HB Jr, et al. Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature. 1994;372:92-94.
10. Du Y, Dodel RC, Eastwood BJ, et al. Association of an interleukin 1[alpha] polymorphism with Alzheimer's disease. Neurology. 2000;55:480-483.
11. Grimaldi LM, Casadei VM, Ferri C, et al. Association of early-onset Alzheimer's disease with an interleukin-1[alpha] gene polymorphism. Ann Neurol. 2000;47:361-365.
12. Nicoll JA, Mrak RE, Graham DI, et al. Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann Neurol. 2000;47:365-368.
13. Dominici R, Cattaneo M, Malferrari G, et al. Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1 alpha. Immunogenetics. 2002;54:82-86.
14. Anderson DR. Automated Static Perimetry. St Louis: Mosby-year Book; 1992:12.
15. McDowell TL, Symons JA, Ploski R, et al. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. Arthritis Rheum. 1995;38:221-228.
16. Schlesselman JJ. Case-Control Studies: Design, Conduct, Analysis. New York: Oxford University Press; 1982.
17. Cartwright MJ, Grajwski AL, Friedberg ML, et al. Immune-related disease and normal tension glaucoma. A case-control study. Arch Ophthalmol. 1992;110:500-502.
18. Yoneda S, Tanihara H, Kido N, et al. Interleukin-1 beta mediates ischemic injury in the rat retina. Exp Eye Res. 2001;73:661-667.
19. Mardin CY, Velten I, Ozbey S, et al. A GLC1A gene Gln368Stop mutation in a patient with normal-tension open-angle glaucoma. J Glaucoma. 1999;8:154-156.
20. Rezaie T, Child A, Hitchings R, et al. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science. 2002;295:1077-1079.
21. Aung T, Ocaka L, Ebenezer ND, et al. Investigating the association between OPA-1 polymorphisms and glaucoma: comparison between normal tension and high tension primary open angle glaucoma. Hum Genet. 2002;110:513-514.
22. Kuo YM, Liao PC, Lin Chingju, et al. Lack of association between interleukin-1alpha polymorphism and Alzheimer disease or vascular dementia. Alzheimer's Dis Assoc Disord. 2003;17:94-97.
23. Li X-Q, Zhang J-W, Zhang Z-X, et al. Interleukin-1 gene cluster polymorphisms and risk of Alzheimer's disease in Chinese Han population. J Neural Transm. 2004;111:1183-1190.
24. Ki CS, Na DL, Kim HJ, et al. Lack of association of the interleukin-1 alpha gene polymorphism with Alzheimer's disease in a Korean population. Ann Neurol. 2001;49:817-818.